SMIM19

gene
On this page

Summary

SMIM19 (small integral membrane protein 19, HGNC:25166) is a protein-coding gene on chromosome 8p11.21, encoding Small integral membrane protein 19 (Q96E16).

Predicted to be located in membrane.

Source: NCBI Gene 114926 — RefSeq curated summary.

At a glance

  • GWAS associations: 7
  • Clinical variants (ClinVar): 25 total
  • MANE Select transcript: NM_001135674

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:25166
Approved symbolSMIM19
Namesmall integral membrane protein 19
Location8p11.21
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000176209
Ensembl biotypeprotein_coding
Entrez114926

Gene structure

Transcript identifiers

Ensembl transcripts: 20 — 18 protein_coding, 1 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined

ENST00000414154, ENST00000416469, ENST00000417410, ENST00000438528, ENST00000490331, ENST00000498447, ENST00000518574, ENST00000529505, ENST00000908389, ENST00000908390, ENST00000908391, ENST00000908392, ENST00000908393, ENST00000908394, ENST00000908395, ENST00000908396, ENST00000908397, ENST00000926900, ENST00000926901, ENST00000966126

RefSeq mRNA: 5 — MANE Select: NM_001135674 NM_001135674, NM_001135675, NM_001135676, NM_001363186, NM_138436

CCDS: CCDS6133

Canonical transcript exons

ENST00000417410 — 4 exons

ExonStartEnd
ENSE000016605574254158542542373
ENSE000035721624254865642548780
ENSE000036138964254646942546606
ENSE000039015244255254442555195

Expression profiles

Bgee: expression breadth ubiquitous, 256 present calls, max score 98.94.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 36.6761 / max 271.7269, expressed in 1819 samples.

FANTOM5 promoters (8 alternative TSS)

Promoter IDTPM avgSamples expressed
8869132.18701819
886922.13081235
886901.77141107
2051720.176558
2051710.148946
886940.137042
886950.072717
886930.051814

Top tissues by expression

256 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
parotid glandUBERON:000183198.94gold quality
left ventricle myocardiumUBERON:000656698.27gold quality
bronchial epithelial cellCL:000232898.24gold quality
kidney epitheliumUBERON:000481998.20gold quality
tibialis anteriorUBERON:000138598.14gold quality
bronchusUBERON:000218597.95gold quality
olfactory segment of nasal mucosaUBERON:000538697.70gold quality
cardiac muscle of right atriumUBERON:000337997.64gold quality
upper arm skinUBERON:000426397.56gold quality
deltoidUBERON:000147697.54gold quality
nasal cavity mucosaUBERON:000182697.51gold quality
vastus lateralisUBERON:000137997.49gold quality
myocardiumUBERON:000234997.34gold quality
biceps brachiiUBERON:000150797.28gold quality
ileal mucosaUBERON:000033197.07gold quality
skeletal muscle tissue of biceps brachiiUBERON:000450296.88gold quality
hindlimb stylopod muscleUBERON:000425296.86gold quality
tendon of biceps brachiiUBERON:000818896.86gold quality
skeletal muscle tissueUBERON:000113496.84gold quality
quadriceps femorisUBERON:000137796.64gold quality
body of pancreasUBERON:000115096.52gold quality
skeletal muscle tissue of rectus abdominisUBERON:000451196.46gold quality
nasal cavity epitheliumUBERON:000538496.28gold quality
tendonUBERON:000004396.26gold quality
right uterine tubeUBERON:000130296.13gold quality
calcaneal tendonUBERON:000370196.13gold quality
muscle tissueUBERON:000238596.11gold quality
upper leg skinUBERON:000426296.07gold quality
skin of hipUBERON:000155496.06gold quality
corpus epididymisUBERON:000435995.99gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes10.18

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

34 targeting SMIM19, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-5692A100.0074.406850
HSA-MIR-4795-3P100.0074.624024
HSA-MIR-433-3P99.9869.371203
HSA-MIR-548AN99.9770.912817
HSA-MIR-211099.9666.681930
HSA-MIR-9-3P99.9670.882068
HSA-MIR-3682-5P99.9367.971163
HSA-MIR-589-3P99.9169.622088
HSA-MIR-380-3P99.8970.181978
HSA-MIR-430799.8270.453374
HSA-MIR-320A-3P99.7769.732107
HSA-MIR-320B99.7769.732107
HSA-MIR-320C99.7769.732107
HSA-MIR-320D99.7769.732107
HSA-MIR-442999.7769.622111
HSA-MIR-3156-3P99.7666.72939
HSA-MIR-494-3P99.7071.452795
HSA-MIR-7154-5P99.6970.521900
HSA-MIR-46699.6770.852863
HSA-MIR-132499.4666.571302
HSA-MIR-6882-5P99.3571.131206
HSA-MIR-120699.3069.321016
HSA-MIR-1273H-3P99.2967.55980
HSA-MIR-6809-5P99.1368.451223
HSA-MIR-3922-5P98.7766.531059
HSA-MIR-1304-3P98.2966.441207
HSA-MIR-316698.2466.631223
HSA-MIR-432-5P98.0068.13989
HSA-MIR-450A-2-3P97.9167.561459
HSA-MIR-6807-5P97.5164.251046

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriosmim19ENSDARG00000037423
mus_musculusSmim19ENSMUSG00000031534
rattus_norvegicusSmim19ENSRNOG00000024930

Protein

Protein identifiers

Small integral membrane protein 19Q96E16 (reviewed: Q96E16)

All UniProt accessions (3): E5RII4, E5RKA7, Q96E16

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Membrane.

Similarity. Belongs to the SMIM19 family.

RefSeq proteins (5): NP_001129146, NP_001129147, NP_001129148, NP_001350115, NP_612445 (=MANE)

Domains & families (InterPro)

IDNameType
IPR029368SMIM19Family

Pfam: PF15117

UniProt features (2 total): chain 1, transmembrane region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q96E16-F168.020.11

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 70 (showing top): E4F1_Q6, RYTTCCTG_ETS2_B, ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN, MARTENS_TRETINOIN_RESPONSE_DN, PEDRIOLI_MIR31_TARGETS_DN, GSE13522_WT_VS_IFNAR_KO_SKING_T_CRUZI_Y_STRAIN_INF_DN, PCGF1_TARGET_GENES, SUPT16H_TARGET_GENES, ZNF618_TARGET_GENES, MIR7154_5P, MIR589_3P, MIR2110, MIR433_3P, GSE11864_CSF1_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP

GO Biological Process (0):

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (1): membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
binding1
cellular anatomical structure1

Protein interactions and networks

STRING

234 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
SMIM19OR8B12Q8NGG6571
SMIM19OR8B3Q8NGG8528
SMIM19ZNF484Q5JVG2514
SMIM19A0A2U3TZT1A0A2U3TZT1506
SMIM19ANKMY2Q8IV38448
SMIM19TBATAQ96M53435
SMIM19SMIM9A6NGZ8432
SMIM19TBC1D8BQ0IIM8431
SMIM19SETD9Q8NE22420
SMIM19C10orf90Q96M02400
SMIM19NXNL1Q96CM4386
SMIM19EME2A4GXA9379
SMIM19DENND5BQ6ZUT9377
SMIM19CPNE8Q86YQ8370
SMIM19KIF12Q96FN5366
SMIM19SLC20A2Q08357366

IntAct

16 interactions, top by confidence:

ABTypeScore
UBQLN2SMIM19psi-mi:“MI:0915”(physical association)0.560
UBQLN1SMIM19psi-mi:“MI:0915”(physical association)0.560
GET3SMIM19psi-mi:“MI:0915”(physical association)0.560
ASPHSMIM19psi-mi:“MI:0915”(physical association)0.560
JAGN1SMIM19psi-mi:“MI:0915”(physical association)0.560
SMIM19UBQLN2psi-mi:“MI:0915”(physical association)0.560
SMIM19UBQLN1psi-mi:“MI:0915”(physical association)0.560
JAGN1SMIM19psi-mi:“MI:0915”(physical association)0.000

BioGRID (7): SMIM19 (Two-hybrid), SMIM19 (Two-hybrid), UBQLN2 (Two-hybrid), ASNA1 (Two-hybrid), ASPH (Two-hybrid), SMIM19 (Proximity Label-MS), SMIM19 (Affinity Capture-MS)

ESM2 similar proteins: A0A1B0GQX3, A0A1B0GRQ0, A0A1B0GV90, A4D0T7, A4QNL6, A6NFZ4, A9RA88, B0CMA4, B3DHH5, C0HJJ0, C1PGW0, D3YUK8, F2Z3Y9, F5HFG3, G1TZA0, G2TRP0, O13001, O14068, O39920, P0DKX4, P34535, P57054, P61807, P61808, Q06FW7, Q19443, Q3E8L0, Q3E912, Q3T0S0, Q4V921, Q54L98, Q5F3W2, Q5R687, Q5RBD8, Q5U4Q2, Q66J27, Q6PQZ3, Q80UA9, Q80ZU4, Q8AUU1

Diamond homologs: A4QNL6, A5D7B5, Q4V921, Q5RBD8, Q80ZU4, Q96E16

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

25 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance22
Likely benign0
Benign1

Top pathogenic / likely-pathogenic (0)

SpliceAI

799 predictions. Top by Δscore:

VariantEffectΔscore
8:42541222:T:TAdonor_gain1.0000
8:42548777:ATTT:Adonor_gain1.0000
8:42548778:TTT:Tdonor_gain1.0000
8:42548781:G:GGdonor_gain1.0000
8:42552532:T:Aacceptor_gain1.0000
8:42552535:T:Aacceptor_gain1.0000
8:42552537:T:TAacceptor_gain1.0000
8:42552542:A:AGacceptor_gain1.0000
8:42552543:G:GGacceptor_gain1.0000
8:42552630:G:GTdonor_gain1.0000
8:42541824:C:Adonor_gain0.9900
8:42546467:A:AGacceptor_gain0.9900
8:42546468:G:GAacceptor_gain0.9900
8:42546468:GC:Gacceptor_gain0.9900
8:42546468:GCC:Gacceptor_gain0.9900
8:42546468:GCCCC:Gacceptor_gain0.9900
8:42546602:AAAAG:Adonor_loss0.9900
8:42546603:AAAG:Adonor_loss0.9900
8:42546604:AAG:Adonor_loss0.9900
8:42546605:AG:Adonor_loss0.9900
8:42546606:GGT:Gdonor_loss0.9900
8:42546607:G:Adonor_loss0.9900
8:42546608:T:Gdonor_loss0.9900
8:42548639:ATG:Aacceptor_gain0.9900
8:42548776:CATTT:Cdonor_gain0.9900
8:42548779:TTGT:Tdonor_loss0.9900
8:42548780:TG:Tdonor_loss0.9900
8:42548781:G:GCdonor_loss0.9900
8:42548782:TAAGT:Tdonor_loss0.9900
8:42548783:A:ATdonor_loss0.9900

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000266422 (8:42547336 G>A,C), RS1000973972 (8:42541276 G>A), RS1001026264 (8:42541568 G>A), RS1001058815 (8:42551084 C>T), RS1001286437 (8:42543835 A>G), RS1001316196 (8:42546709 A>G), RS1001402389 (8:42543451 G>T), RS1001584198 (8:42550226 C>T), RS1002469777 (8:42540691 T>C), RS1002700846 (8:42545392 G>A), RS1003078896 (8:42552217 A>C), RS1003313941 (8:42543578 A>G), RS1003415000 (8:42550537 C>T), RS1003747467 (8:42542253 C>A,T), RS1003849503 (8:42542124 G>T)

Disease associations

OMIM: gene `` | disease phenotypes: MIM:213600, MIM:606656

GenCC curated gene-disease

Mondo (1): basal ganglia calcification, idiopathic, 1 (MONDO:0024538)

Orphanet (1): Bilateral striopallidodentate calcinosis (Orphanet:1980)

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

7 associations (top):

StudyTraitp-value
GCST003854_24Gut microbiota (functional units)4.000000e-08
GCST004329_1Mean corpuscular hemoglobin concentration5.000000e-07
GCST004329_2Mean corpuscular hemoglobin concentration3.000000e-11
GCST010083_246Hemoglobin levels8.000000e-26
GCST010703_179Brain morphology (MOSTest)5.000000e-11
GCST90000047_154Age at first sexual intercourse1.000000e-10
GCST90002384_175Hemoglobin1.000000e-33

EFO canonical traits (5, from GWAS)

EFO IDTrait name
EFO:0007874gut microbiome measurement
EFO:0004528mean corpuscular hemoglobin concentration
EFO:0004509hemoglobin measurement
EFO:0004346neuroimaging measurement
EFO:0009749age at first sexual intercourse measurement

MeSH disease descriptors (1)

DescriptorNameTree numbers
C537657Basal ganglia calcification, idiopathic 2 (supp.)

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

29 total (human), top 29 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidaffects expression, decreases expression4
GSK-J4decreases expression1
resorcinoldecreases expression1
di-n-butylphosphoric acidaffects expression1
ICG 001increases expression1
pyrachlostrobindecreases expression1
picoxystrobindecreases expression1
Sunitinibdecreases expression1
Air Pollutantsincreases abundance, decreases expression1
Benzo(a)pyreneaffects methylation1
Doxorubicinincreases expression1
Estradioldecreases expression1
Formaldehydeincreases expression1
Hydrogen Peroxideaffects expression1
Ketoconazoledecreases expression1
Quercetindecreases expression1
Smokeincreases expression1
Tretinoindecreases expression1
Tunicamycinincreases expression1
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxideincreases expression1
Cyclosporinedecreases expression1
Aflatoxin B1decreases methylation1
Antirheumatic Agentsincreases expression1
Okadaic Aciddecreases expression1
Copper Sulfatedecreases expression1
Lactic Aciddecreases expression1
tert-Butylhydroperoxideaffects expression1
Vitamin K 3affects expression1
Particulate Matterdecreases expression, increases abundance1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.